Synthesis and biological evaluation of 2-arylbenzofuran derivatives as potential anti-Alzheimer’s disease agents

Synthesis and biological evaluation of 2-arylbenzofuran derivatives as potential anti-Alzheimer’s disease agents

Alzheimer's disease (AD) is a type of progressive dementia caused by degeneration of the nervous system. A single target drug usually does not work well. Therefore, multi-target drugs are designed and developed so that one drug can specifically bind to multiple targets to ensure clinical effect...

Full description

Bibliographic Details
Main Authors:	Yinling Yun, Yuhang Miao, Xiaoya Sun, Jie Sun, Xiaojing Wang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-01-01
Series:	Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:	2-arylbenzofuran derivatives alzheimer's disease cholinesterase inhibitors β-secretase inhibitory activity
Online Access:	http://dx.doi.org/10.1080/14756366.2021.1940993

Similar Items

Synthesis and biological evaluation of 3-arylbenzofuranone derivatives as potential anti-Alzheimer’s disease agents
by: Jie Yang, et al.
Published: (2020-01-01)

Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
by: Martina Zimmermann, et al.
Published: (2005-06-01)

New 2-Arylbenzofurans from the Root Bark of Artocarpus lakoocha
by: Boonchoo Sritularak, et al.
Published: (2010-09-01)

Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity
by: Ericsson Coy-Barrera
Published: (2020-01-01)

Insight into the PTP1B Inhibitory Activity of Arylbenzofurans: An In Vitro and In Silico Study
by: Srijan Shrestha, et al.
Published: (2019-08-01)

Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents
by: Jie Yang, et al.
Published: (2019-01-01)

Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
by: Jing Zhao, et al.
Published: (2020-08-01)

Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
by: Tosin A. Olasehinde, et al.
Published: (2017-03-01)

Synthesis of <i>N</i>′-(4-/3-/2-/Non-substituted benzylidene)-4-[(4-methylphenyl)sulfonyloxy] Benzohydrazides and Evaluation of Their Inhibitory Activities against Monoamine Oxidases and β-Secretase
by: Hasan Erdinç Sellitepe, et al.
Published: (2021-06-01)

Multidirectional in vitro and in cellulo studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer’s disease
by: Natalia Szałaj, et al.
Published: (2020-01-01)

Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders
by: Giovanni B Frisoni, et al.
Published: (2021-08-01)

Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer’s Disease
by: Tosin A. Olasehinde, et al.
Published: (2019-10-01)

Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents
by: Dawid Panek, et al.
Published: (2018-02-01)

CHOLINESTERASE INHIBITORS IN THE TREATMENT OF DEMENTIA ALZHEIMER’S
by: Prameidya Primaniar S
Published: (2013-03-01)

Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease
by: Hafsa Amat-ur-Rasool, et al.
Published: (2021-02-01)

Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors
by: Keith D. Green, et al.
Published: (2018-12-01)

Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer’s Disease
by: Angela Rampa, et al.
Published: (2018-07-01)

Shrimp (Pandalopsis dispar) waste hydrolysate as a source of novel β–secretase inhibitors
by: Eunice C. Y. Li-Chan, et al.
Published: (2016-04-01)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
by: Ben Seltzer
Published: (2009-12-01)

New flavonoid – N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties
by: Martín Estrada-Valencia, et al.
Published: (2019-01-01)

Alzheimer’s Disease: Current and Future Treatments. A Review
by: Evelyn Chou
Published: (2014-05-01)

Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer’s Disease
by: Marcus O. W. Grimm, et al.
Published: (2016-10-01)

Purification and characterization of β-secretase inhibitory peptide from sea hare (Aplysia kurodai) by enzymatic hydrolysis
by: Jung Kwon Lee, et al.
Published: (2018-05-01)

Soluble Gamma-secretase Modulators Attenuate Alzheimer's β-amyloid Pathology and Induce Conformational Changes in Presenilin 1
by: Frank Raven, et al.
Published: (2017-10-01)

Anti-Amyloid Aggregation Activity of Black Sesame Pigment: Toward a Novel Alzheimer’s Disease Preventive Agent
by: Lucia Panzella, et al.
Published: (2018-03-01)

Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants
by: Muhammad Ayaz, et al.
Published: (2017-05-01)

Efeito de inibidor da acetilcolinesterase no metabolismo da proteína precursora do amiloide em plaquetas
by: Tamires Alves Sarno
Published: (2016)

Efeito de inibidor da acetilcolinesterase no metabolismo da proteína precursora do amiloide em plaquetas
by: Sarno, Tamires Alves
Published: (2016)

The Role of microRNAs in Alzheimer’s Disease and Their Therapeutic Potentials
by: Munvar Miya Shaik, et al.
Published: (2018-03-01)

Evaluation of Asarum europaeum L. Rhizome for the Biological Activities Related to Alzheimer’s Disease
by: Mina Saeedi, et al.
Published: (2020-07-01)

In Vitro Enzymatic and Kinetic Studies, and In Silico Drug-Receptor Interactions, and Drug-Like Profiling of the 5-styrylbenzamide Derivatives as Potential Cholinesterase and β-secretase Inhibitors with Antioxidant Properties
by: Malose J. Mphahlele, et al.
Published: (2021-04-01)

Design, synthesis and evaluation of quinolinone derivatives containing dithiocarbamate moiety as multifunctional AChE inhibitors for the treatment of Alzheimer’s disease
by: Jie Fu, et al.
Published: (2020-01-01)

The specific features of using a rivastigmine transdermal formulation in Alzheimer’s disease
by: Elena Evgenyevna Vasenina, et al.
Published: (2012-09-01)

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease
by: Youssef Dgachi, et al.
Published: (2016-05-01)

One Pot Synthesis of Micromolar BACE-1 Inhibitors Based on the Dihydropyrimidinone Scaffold and Their Thia and Imino Analogues
by: Jessica Bais, et al.
Published: (2020-09-01)

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy
by: Houssem Boulebd, et al.
Published: (2016-03-01)

Computer-assisted evaluation of plant-derived β-secretase inhibitors in Alzheimer’s disease
by: Md. Asad Ullah, et al.
Published: (2021-04-01)

Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
by: Gabriela Dumitrita Stanciu, et al.
Published: (2019-12-01)

Galantamine plasma concentration and cognitive response in Alzheimer’s disease
by: Yi-Ting Lin, et al.
Published: (2019-05-01)

FINANCIAL AVAILABILITY OF IN-HOME MEDICAL TREATMENT OF PATIENTS WITH ALZHEIMER’S DISEASE
by: Mariana Arnaoudova, et al.
Published: (2016-07-01)